Literature DB >> 10587828

Body mass index, diabetes, and C-reactive protein among U.S. adults.

E S Ford1.   

Abstract

OBJECTIVE: The author examined the relationship between C-reactive protein and BMI and diabetes status among 16,573 participants aged > or = 20 years of the Third National Health and Nutrition Examination Survey (1988-1994). RESEARCH DESIGN AND METHODS: The study had a cross-sectional design.
RESULTS: Geometric mean concentrations of C-reactive protein were lowest among individuals with a BMI < 18.5 kg/m2 and increased with increasing BMI categories. Restricting the analysis to participants without various medical conditions did not change the relation. After adjusting for age, sex, race or ethnicity, and education, using logistic regression analysis, odds ratios for an elevated C-reactive protein concentration (> or = 85th percentile of the sex-specific C-reactive protein concentration distribution) among participants with a BMI of 25 to < 30, 30 to < 35, 35 to < 40, and > or = 40 kg/m2 were 1.51 (95% CI 1.23-1.86), 3.19 (2.60-3.91), 6.11 (4.67-7.98), and 9.30 (6.43-13.46), respectively, compared with participants with a BMI < 25 kg/m2. C-reactive protein concentrations were lowest among those individuals without diabetes or with impaired fasting glucose and highest among those with newly or previously diagnosed diabetes. Compared with participants with a normal fasting glucose, participants with impaired fasting glucose, newly diagnosed diabetes, and previously diagnosed diabetes had 0.99 (0.72-1.37), 1.84 (1.25-2.71), and 1.59 (1.25-2.01) odds of having an elevated C-reactive protein concentration after adjustment for age, sex, race or ethnicity, education, and BMI.
CONCLUSIONS: These results confirm cross-sectional findings from previous studies that show elevated C-reactive protein concentrations among individuals who are obese or have diabetes. The implications of these findings, however, remain unclear.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10587828     DOI: 10.2337/diacare.22.12.1971

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  119 in total

Review 1.  C-reactive protein: a critical update.

Authors:  Mark B Pepys; Gideon M Hirschfield
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

2.  Impact of Vitamin E Supplementation on Blood Pressure and Hs-CRP in Type 2 Diabetic Patients | doi: 10.5681/hpp.2012.009.

Authors:  Maryam Rafraf; Behnaz Bazyun; Mohammad Ali Sarabchian; Abdolrasoul Safaeiyan; Seyed Jamal Ghaemmaghami Hezaveh
Journal:  Health Promot Perspect       Date:  2012-07-01

Review 3.  Inflammation and diabetic nephropathy.

Authors:  Carmen Mora; Juan F Navarro
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

4.  High-sensitivity C-reactive protein and ankle brachial index in a finnish cardiovascular risk population.

Authors:  K Syvänen; P Korhonen; P Jaatinen; T Vahlberg; P Aarnio
Journal:  Int J Angiol       Date:  2011-03

5.  Nutrigenomics, beta-cell function and type 2 diabetes.

Authors:  R Nino-Fong; Tm Collins; Cb Chan
Journal:  Curr Genomics       Date:  2007-03       Impact factor: 2.236

Review 6.  Diabetic neuropathy in older adults.

Authors:  Aaron I Vinik; Elsa S Strotmeyer; Abhijeet A Nakave; Chhaya V Patel
Journal:  Clin Geriatr Med       Date:  2008-08       Impact factor: 3.076

7.  Vitamin C treatment reduces elevated C-reactive protein.

Authors:  Gladys Block; Christopher D Jensen; Tapashi B Dalvi; Edward P Norkus; Mark Hudes; Patricia B Crawford; Nina Holland; Ellen B Fung; Laurie Schumacher; Paul Harmatz
Journal:  Free Radic Biol Med       Date:  2008-10-10       Impact factor: 7.376

Review 8.  Role of adipocytokines in predicting the development of diabetes and its late complications.

Authors:  Nese Ersoz Gulcelik; Aydan Usman; Alper Gürlek
Journal:  Endocrine       Date:  2009-09-25       Impact factor: 3.633

9.  The impact of intra-articular methylprednisolone acetate injection on fructosamine levels in diabetic patients with osteoarthritis of the knee, a case-control study.

Authors:  George Habib; Fahed Sakas; Suheil Artul; Fadi Khazin; Geries Hakim; Adel Jabbour; Haneen Jabaly-Habib
Journal:  Clin Rheumatol       Date:  2016-03-07       Impact factor: 2.980

10.  Discordances among different tools used to estimate cardiovascular risk in postmenopausal women.

Authors:  Pascal Pelletier; Annie Lapointe; Nathalie Laflamme; Marie-Eve Piché; Stanley John Weisnagel; André Nadeau; Simone Lemieux; Jean Bergeron
Journal:  Can J Cardiol       Date:  2009-12       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.